Sharescart Research Club logo ×
Screener Research Unlisted Startup Funding New IPO New

  • Home
  • /
  • Dr Lalchandani Labs
Join Channel
Consolidated Standalone

Dr Lalchandani Labs

₹20 -1.9 | 8.7%

Market Cap ₹9 Cr.

Stock P/E

P/B 1

Current Price ₹20

Book Value ₹ 20.6

Face Value 10

52W High ₹35

Dividend Yield 0%

52W Low ₹ 15.7

Edit Ratio

Dr Lalchandani Labs Research see more...

Overview Inc. Year: 2011Industry: Hospital & Healthcare Services

Dr Lalchandani Labs Ltd presents diagnostic and associated healthcare tests and services in India. It offers doctor consultation, blood test, urine test, ultrasound, virtual x-ray, electo-cardiography, treadmill test, 2D echo-cardiography, HSG test, pulmonary feature test, nerve-conduction-velocity, electroencephalogram, electormyography, onsite and offsite corporate fitness test, health center lab management, home collection of samples, gulf medical check, delivery marine sailor fitness check, insurance health check, and pre-employment fitness test services for use within the core testing, patient diagnosis and prevention, tracking, and treatment of sickness and other health conditions. The organisation additionally provides COVID-19 checks, which consist of RT-PCR, speedy antigen, and antibody tests. It serves individual patients, hospitals and other healthcare carriers, and corporate customers. The agency was founded in 1986 and is based in New Delhi, India.

Read More..

Dr Lalchandani Labs Share Price

New

₹ | |

Volume
Price

Quarterly Price

Quarterly Monthly
Show Value Show %

Peer Comparison

Dr Lalchandani Labs Quarterly Results

#(Fig in Cr.)
Net Sales
Other Income
Total Income
Total Expenditure
Operating Profit
Interest
Depreciation
Exceptional Income / Expenses
Profit Before Tax
Provision for Tax
Profit After Tax
Adjustments
Profit After Adjustments
Adjusted Earnings Per Share

Dr Lalchandani Labs Profit & Loss

#(Fig in Cr.) Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 TTM
Net Sales 3 5 6 10 11 5
Other Income 0 0 0 0 0 0
Total Income 3 5 6 10 11 5
Total Expenditure 2 4 5 8 9 5
Operating Profit 1 1 1 2 2 0
Interest 0 0 0 0 1 1
Depreciation 0 0 0 1 1 1
Exceptional Income / Expenses 0 0 0 0 0 0
Profit Before Tax 0 1 1 1 1 -2
Provision for Tax 0 0 0 0 0 0
Profit After Tax 0 1 0 1 1 -2
Adjustments 0 0 0 0 0 0
Profit After Adjustments 0 1 0 1 1 -2
Adjusted Earnings Per Share 0.9 1.2 1.1 2.3 2.2 -3.6

Growth Rates

# 1 Year 3 Year 5 Year 10 Year
Sales CAGR -55% -6% 11% 0%
Operating Profit CAGR -100% -100% -100% 0%
PAT CAGR -300% 0% 0% 0%
# 1 Year 3 Year 5 Year 10 Year
Share Price CAGR -22% -11% 2% NA%
ROE Average -16% 2% 4% 5%
ROCE Average -4% 8% 9% 9%

Dr Lalchandani Labs Balance Sheet

#(Fig in Cr.) Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Shareholder's Funds 3 8 9 10 10 9
Minority's Interest 0 0 0 0 0 0
Borrowings 1 1 1 3 3 3
Other Non-Current Liabilities 0 0 0 0 0 0
Total Current Liabilities 2 1 2 3 5 5
Total Liabilities 6 10 12 15 18 18
Fixed Assets 2 3 3 5 6 5
Other Non-Current Assets 0 1 1 1 1 1
Total Current Assets 4 6 8 9 11 11
Total Assets 6 10 12 15 18 18

Dr Lalchandani Labs Cash Flow

#(Fig in Cr.) Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Opening Cash & Cash Equivalents 0 1 2 2 3 4
Cash Flow from Operating Activities 1 -0 -0 1 2 0
Cash Flow from Investing Activities -1 -2 -1 -2 -2 -0
Cash Flow from Financing Activities 2 4 1 2 0 -0
Net Cash Inflow / Outflow 1 1 0 1 1 -0
Closing Cash & Cash Equivalent 1 2 2 3 4 3

Dr Lalchandani Labs Ratios

# Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Earnings Per Share (Rs) 0.89 1.23 1.09 2.33 2.15 -3.61
CEPS(Rs) 1.34 2.04 2.07 3.52 3.51 -2.08
DPS(Rs) 0 0 0 0 0 0
Book NAV/Share(Rs) 11.03 17.53 18.88 21.48 23.9 20.56
Core EBITDA Margin(%) 22.11 22.78 20.79 22.98 21.91 1.77
EBIT Margin(%) 18.44 16.26 13.86 17.71 16.71 -11.28
Pre Tax Margin(%) 12.73 13.67 10.83 14.08 11.41 -31.01
PAT Margin (%) 9.42 10.14 7.77 10.34 8.27 -31.01
Cash Profit Margin (%) 14.11 16.77 14.7 15.61 13.49 -17.85
ROA(%) 4.23 6.53 4.3 7.46 5.6 -8.72
ROE(%) 8.11 9.85 6.01 11.56 9.49 -16.23
ROCE(%) 10.06 12.57 9.17 14.88 13.07 -3.69
Receivable days 149.45 102.96 154.12 136.38 132.62 332.44
Inventory Days 35.53 23.01 26.58 21.91 36.13 111.46
Payable days 400.13 411.81 287.38 105.53 146.8 416.11
PER(x) 0 15.84 7.41 5.96 15.32 0
Price/Book(x) 0 1.11 0.43 0.65 1.38 1.38
Dividend Yield(%) 0 0 0 0 0 0
EV/Net Sales(x) 1.4 1.39 0.49 0.73 1.41 3.1
EV/Core EBITDA(x) 6.05 6.09 2.38 3.19 6.44 165.56
Net Sales Growth(%) 0 88.81 16.02 60.23 15.32 -55.31
EBIT Growth(%) 0 66.43 -1.12 104.81 8.8 -130.17
PAT Growth(%) 0 103.32 -11.11 113.24 -7.71 -267.45
EPS Growth(%) 0 37.62 -11.11 113.24 -7.71 -267.45
Debt/Equity(x) 0.58 0.12 0.21 0.43 0.5 0.72
Current Ratio(x) 2.38 4.11 4.07 2.98 2.22 2.07
Quick Ratio(x) 2.21 3.83 3.8 2.75 1.9 1.78
Interest Cover(x) 3.23 6.27 4.57 4.88 3.15 -0.57
Total Debt/Mcap(x) 0 0.11 0.5 0.67 0.36 0.52

Dr Lalchandani Labs Shareholding Pattern

# Sep 2019 Mar 2020 Sep 2020 Mar 2021 Sep 2021 Mar 2022 Sep 2022 Mar 2023 Sep 2023 Mar 2024
Promoter 60.78 60.78 60.78 60.78 60.78 60.78 60.78 60.78 60.78 60.78
FII 0 0 0 0 0 0 0 0 0 0
DII 0 0 0 0 0 0 0 0 0 0
Public 39.22 39.22 39.22 39.22 39.22 39.22 39.22 39.22 39.22 39.22
Others 0 0 0 0 0 0 0 0 0 0
Total 100 100 100 100 100 100 100 100 100 100

Pros

Cons

  • Company has a low return on equity of 2% over the last 3 years.
  • Debtor days have increased from 146.8 to 416.11days.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Dr Lalchandani Labs News

Top Unlisted Companies & InstaBuy Companies

Sell or Purchase Share (Tentative Price)

IPO

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

You May Also Know About

Unlisted Shares Pre-IPO Shares ESOP Shares Delisted Shares

Please Login!

Click to Login
OR
Get free Account

Error!